» Articles » PMID: 2998767

T Antigen and Template Requirements for SV40 DNA Replication in Vitro

Overview
Journal EMBO J
Date 1985 Nov 1
PMID 2998767
Citations 99
Authors
Affiliations
Soon will be listed here.
Abstract

A cell-free system for replication of SV40 DNA was used to assess the effect of mutations altering either the SV40 origin of DNA replication or the virus-encoded large tumor (T) antigen. Plasmid DNAs containing various portions of the SV40 genome that surround the origin of DNA replication support efficient DNA synthesis in vitro and in vivo. Deletion of DNA sequences adjacent to the binding sites for T antigen either reduce or prevent DNA synthesis. This analysis shows that sequences that had been previously defined by studies in vivo to constitute the minimal core origin sequences are also necessary for DNA synthesis in vitro. Five mutant T antigens containing amino acid substitutions that affect SV40 replication have been purified and their in vitro properties compared with the purified wild-type protein. One protein is completely defective in the ATPase activity of T antigen, but still binds to the origin sequences. Three altered proteins are defective in their ability to bind to origin DNA, but retain ATPase activity. Finally, one of the altered T antigens binds to origin sequences and contains ATPase activity and thus appears like wild-type for these functions. All five proteins fail to support SV40 DNA replication in vitro. Interestingly, in mixing experiments, all five proteins efficiently compete with the wild-type protein and reduce the amount of DNA replication. These data suggest that an additional function of T antigen other than origin binding or ATPase activity, is required for initiation of DNA replication.

Citing Articles

Single-Cell Transcriptomics Reveals a Heterogeneous Cellular Response to BK Virus Infection.

An P, Cantalupo P, Zheng W, Saenz-Robles M, Duray A, Weitz D J Virol. 2020; 95(6).

PMID: 33361432 PMC: 8094954. DOI: 10.1128/JVI.02237-20.


Absence of MutSβ leads to the formation of slipped-DNA for CTG/CAG contractions at primate replication forks.

Slean M, Panigrahi G, Castel A, Pearson A, Tomkinson A, Pearson C DNA Repair (Amst). 2016; 42:107-18.

PMID: 27155933 PMC: 5096786. DOI: 10.1016/j.dnarep.2016.04.002.


Validating the disruption of proliferating cell nuclear antigen interactions in the development of targeted cancer therapeutics.

Smith S, Hickey R, Malkas L Cancer Biol Ther. 2016; 17(3):310-9.

PMID: 26889573 PMC: 4847981. DOI: 10.1080/15384047.2016.1139247.


Simian virus Large T antigen interacts with the N-terminal domain of the 70 kD subunit of Replication Protein A in the same mode as multiple DNA damage response factors.

Ning B, Feldkamp M, Cortez D, Chazin W, Friedman K, Fanning E PLoS One. 2015; 10(2):e0116093.

PMID: 25706313 PMC: 4337903. DOI: 10.1371/journal.pone.0116093.


The Mcm2-7 replicative helicase: a promising chemotherapeutic target.

Simon N, Schwacha A Biomed Res Int. 2014; 2014:549719.

PMID: 25243149 PMC: 4163376. DOI: 10.1155/2014/549719.


References
1.
Wasylyk B, Wasylyk C, Matthes H, Wintzerith M, Chambon P . Transcription from the SV40 early-early and late-early overlapping promoters in the absence of DNA replication. EMBO J. 1983; 2(9):1605-11. PMC: 555330. DOI: 10.1002/j.1460-2075.1983.tb01631.x. View

2.
Stillman B, Gluzman Y . Replication and supercoiling of simian virus 40 DNA in cell extracts from human cells. Mol Cell Biol. 1985; 5(8):2051-60. PMC: 366923. DOI: 10.1128/mcb.5.8.2051-2060.1985. View

3.
Danna K, Nathans D . Bidirectional replication of Simian Virus 40 DNA. Proc Natl Acad Sci U S A. 1972; 69(11):3097-100. PMC: 389712. DOI: 10.1073/pnas.69.11.3097. View

4.
Tegtmeyer P, Rundell K, Collins J . Modification of simian virus 40 protein A. J Virol. 1977; 21(2):647-57. PMC: 353867. DOI: 10.1128/JVI.21.2.647-657.1977. View

5.
Subramanian K, Shenk T . Definition of the boundaries of the origin of DNA replication in simian virus 40. Nucleic Acids Res. 1978; 5(10):3635-42. PMC: 342700. DOI: 10.1093/nar/5.10.3635. View